High Acceptance Seen for Liver Stiffness Test With Routine Retina Scan in T2DM

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 20, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Dec. 20, 2024 -- For individuals with type 2 diabetes, examination with vibration-controlled transient elastography (VCTE) alongside retina scanning has a high acceptance rate, but false-positive findings seem to be common, according to a study published online Dec. 12 in The Lancet Gastroenterology & Hepatology.

Andrea Lindfors, M.D., from the Karolinska University Hospital in Stockholm, and colleagues conducted a cross-sectional study in which people with type 2 diabetes referred to routine retina scanning were offered VCTE. Participants with a liver stiffness measurement of at least 8.0 kPa or those with unreliable measurements were referred for a secondary evaluation, which included follow-up VTCE.

Overall, 1,005 of 1,301 participants who were eligible for assessment with VCTE (77.2 percent) accepted assessment. The researchers found that 973 participants (96.8 percent) had complete measurements, and of these, 504 (51.8 percent) had controlled attenuation parameter values of 280 dB/m or higher, indicative of metabolic dysfunction-associated steatotic liver disease. Reliable liver stiffness measurements were available for 977 participants; 154 (15.8 percent) had values of at least 8.0 kPa and 49 (5.0 percent) had values higher than 12.0 kPa, suggestive of liver fibrosis and possible advanced fibrosis, respectively. Upon reassessment with a second VCTE after referral, 45.2 percent of 124 individuals had values less than 8.0 kPa. Overall, 7.4 and 2.9 percent of 1,005 participants had a final liver stiffness of at least 8.0 kPa and greater than 12.0 kPa, respectively.

"A high proportion of participants with an initial elevated liver stiffness measurement with VCTE did not have elevated liver stiffness measurements at the second visit," the authors write. "This risk must be considered if implementing this method into clinical routine."

One author disclosed ties to pharmaceutical companies, including Pfizer and Gilead, which funded the study.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-21 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords